These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22837097)

  • 21. Broad, high-magnitude and multifunctional CD4+ and CD8+ T-cell responses elicited by a DNA and modified vaccinia Ankara vaccine containing human immunodeficiency virus type 1 subtype C genes in baboons.
    Burgers WA; Chege GK; Müller TL; van Harmelen JH; Khoury G; Shephard EG; Gray CM; Williamson C; Williamson AL
    J Gen Virol; 2009 Feb; 90(Pt 2):468-480. PubMed ID: 19141458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine.
    Yan J; Corbitt N; Pankhong P; Shin T; Khan A; Sardesai NY; Weiner DB
    Vaccine; 2011 Sep; 29(41):7173-81. PubMed ID: 21651948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies.
    Young KR; Teal BE; Brooks Y; Green TD; Bower JF; Ross TM
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1259-68. PubMed ID: 15588348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High antibody and cellular responses induced to HIV-1 clade C envelope following DNA vaccines delivered by electroporation.
    Yin J; Dai A; Lecureux J; Arango T; Kutzler MA; Yan J; Lewis MG; Khan A; Sardesai NY; Montefiore D; Ruprecht R; Weiner DB; Boyer JD
    Vaccine; 2011 Sep; 29(39):6763-70. PubMed ID: 21195801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased generation of HIV-1 gp120-reactive CD8+ T cells by a DNA vaccine construct encoding the chemokine CCL3.
    Øynebråten I; Hinkula J; Fredriksen AB; Bogen B
    PLoS One; 2014; 9(8):e104814. PubMed ID: 25122197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Priming with DNA Expressing Trimeric HIV V1V2 Alters the Immune Hierarchy Favoring the Development of V2-Specific Antibodies in Rhesus Macaques.
    Devasundaram S; Rosati M; Valentin A; Weiss S; Itri V; Trinh HV; Bear J; Chowdhury B; LaBranche CC; Montefiori D; Ferrari G; Rao M; Kong XP; Zolla-Pazner S; Pavlakis GN; Felber BK
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33087466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles.
    Bridge SH; Sharpe SA; Dennis MJ; Dowall SD; Getty B; Anson DS; Skinner MA; Stewart JP; Blanchard TJ
    Virol J; 2011 Sep; 8():429. PubMed ID: 21899739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7.
    Lertjuthaporn S; Cicala C; Van Ryk D; Liu M; Yolitz J; Wei D; Nawaz F; Doyle A; Horowitch B; Park C; Lu S; Lou Y; Wang S; Pan R; Jiang X; Villinger F; Byrareddy SN; Santangelo PJ; Morris L; Wibmer CK; Biris K; Mason RD; Gorman J; Hiatt J; Martinelli E; Roederer M; Fujikawa D; Gorini G; Franchini G; Arakelyan A; Ansari AA; Pattanapanyasat K; Kong XP; Fauci AS; Arthos J
    PLoS Pathog; 2018 Aug; 14(8):e1007278. PubMed ID: 30153309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions.
    Lu S; Wyatt R; Richmond JF; Mustafa F; Wang S; Weng J; Montefiori DC; Sodroski J; Robinson HL
    AIDS Res Hum Retroviruses; 1998 Jan; 14(2):151-5. PubMed ID: 9462925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmid DNA vaccination using skin electroporation promotes poly-functional CD4 T-cell responses.
    Bråve A; Nyström S; Roos AK; Applequist SE
    Immunol Cell Biol; 2011 Mar; 89(3):492-6. PubMed ID: 20838412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation.
    Vandermeulen G; Vanvarenberg K; De Beuckelaer A; De Koker S; Lambricht L; Uyttenhove C; Reschner A; Vanderplasschen A; Grooten J; Préat V
    Vaccine; 2015 Jun; 33(28):3179-85. PubMed ID: 25980430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B' recombinant.
    Huang Y; Chen Z; Zhang W; Gurner D; Song Y; Gardiner DF; Ho DD
    J Acquir Immune Defic Syndr; 2008 Apr; 47(4):403-11. PubMed ID: 18209683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4.
    Nayak BP; Sailaja G; Jabbar AM
    J Virol; 2003 Oct; 77(20):10850-61. PubMed ID: 14512535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons.
    Corbet S; Vinner L; Hougaard DM; Bryder K; Nielsen HV; Nielsen C; Fomsgaard A
    AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1997-2008. PubMed ID: 11153083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The V2 loop of HIV gp120 delivers costimulatory signals to CD4
    Goes LR; Sajani A; Sivro A; Olowojesiku R; Ray JC; Perrone I; Yolitz J; Girard A; Leyre L; Wibmer CK; Morris L; Gorini G; Franchini G; Mason RD; Roederer M; Mehandru S; Soares MA; Cicala C; Fauci AS; Arthos J
    Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32566-32573. PubMed ID: 33288704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand.
    Sailaja G; Husain S; Nayak BP; Jabbar AM
    J Immunol; 2003 Mar; 170(5):2496-507. PubMed ID: 12594275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroporation-mediated administration of candidate DNA vaccines against HIV-1.
    Vasan S
    Methods Mol Biol; 2014; 1121():291-307. PubMed ID: 24510833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasticity and Epitope Exposure of the HIV-1 Envelope Trimer.
    Powell RLR; Totrov M; Itri V; Liu X; Fox A; Zolla-Pazner S
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat.
    Cristillo AD; Galmin L; Restrepo S; Hudacik L; Suschak J; Lewis B; Draghia-Akli R; Aziz N; Weiss D; Markham P; Pal R
    Biochem Biophys Res Commun; 2008 May; 370(1):22-6. PubMed ID: 18329382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.